Inyx Inc. (IYXI)

Overview

Inyx, Inc. is a specialty pharmaceutical company that has established its presence across the United States, Canada, and Europe through its wholly-owned subsidiaries. Incorporated in 2000 and basing its operations in New York, New York, Inyx, Inc. dedicates itself to the development and manufacturing of both prescription and over-the-counter pharmaceutical products. With a particular focus on delivery systems for various applications, including dermatological, respiratory, and cardiovascular ailments among others, the company also engages in vigorous research and development. This is aimed at advancing inhalation-therapy drug delivery devices, as well as producing generic versions of aerosol pharmaceutical products. Additionally, Inyx provides specialty consulting services in pharmaceutical development and manufacturing to the global healthcare market.

Products and Services

• Hydrocarbon Aerosols: These are utilized as a delivery system for dermatological and topical drug applications, providing an innovative approach to treatment.
• Metered Dose Inhalers: Specifically designed for respiratory conditions, these inhalers ensure precise doses of medication are delivered directly to the lungs.
• Dry Powdered Inhalers: Another respiratory aid, these are used for delivering medication in dry powder form to individuals with respiratory ailments.
• Metered Dose Nasal and Throat Pumps, and Sprays: These devices offer targeted delivery for nasal and throat conditions, aiding in more effective treatment.
• Sterile Salines and Injectables: Essential for various medical applications, these are manufactured with the highest standards of purity and sterility.
• Research and Development in Inhalation-Therapy: Inyx focuses on developing advanced drug delivery devices and methods for inhalation therapy, catering to respiratory, allergy, dermatological, and cardiovascular applications.
• Generic Prescription and Over-the-Counter Aerosol Pharmaceuticals: The company is actively working on the development of generic versions of nonchlorofluorocarbon (nonCFC) or hydrofluoroalkane (HFA) single molecule and combination drug respiratory inhalants, oral sprays for cardiovascular ailments, wound irrigation and cleansing sprays, and anti-inflammatory nasal pumps.
• Specialty Pharmaceutical Development and Manufacturing Consulting: Beyond its proprietary products, Inyx extends its expertise to provide consulting services on specialty pharmaceutical development and manufacturing to the international healthcare market.